ID   PLK2_RAT                Reviewed;         682 AA.
AC   Q9R012;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JUL-2024, entry version 162.
DE   RecName: Full=Serine/threonine-protein kinase PLK2;
DE            EC=2.7.11.21;
DE   AltName: Full=Polo-like kinase 2;
DE            Short=PLK-2;
DE   AltName: Full=Serine/threonine-protein kinase SNK;
DE   AltName: Full=Serum-inducible kinase;
GN   Name=Plk2; Synonyms=Snk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH CIB1.
RX   PubMed=10523297; DOI=10.1093/emboj/18.20.5528;
RA   Kauselmann G., Weiler M., Wulff P., Jessberger S., Konietzko U.,
RA   Scafidi J., Staubli U., Bereiter-Hahn J., Strebhardt K., Kuhl D.;
RT   "The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and
RT   integrin-binding protein and are regulated dynamically with synaptic
RT   plasticity.";
RL   EMBO J. 18:5528-5539(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION IN PHOSPHORYLATION OF SIPA1L1, AND MUTAGENESIS OF ASP-202.
RX   PubMed=18723513; DOI=10.1074/jbc.m802475200;
RA   Ang X.L., Seeburg D.P., Sheng M., Harper J.W.;
RT   "Regulation of postsynaptic RapGAP SPAR by Polo-like kinase 2 and the
RT   SCFbeta-TRCP ubiquitin ligase in hippocampal neurons.";
RL   J. Biol. Chem. 283:29424-29432(2008).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF SIPA1L1, AND MUTAGENESIS OF TRP-504.
RX   PubMed=18498738; DOI=10.1016/j.neuron.2008.03.021;
RA   Seeburg D.P., Feliu-Mojer M., Gaiottino J., Pak D.T., Sheng M.;
RT   "Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic
RT   plasticity during elevated activity.";
RL   Neuron 58:571-583(2008).
RN   [5]
RP   FUNCTION, INTERACTION WITH NSF, PHOSPHORYLATION AT THR-236, AND MUTAGENESIS
RP   OF LYS-108; THR-236 AND TRP-504.
RX   PubMed=20802490; DOI=10.1038/nn.2624;
RA   Evers D.M., Matta J.A., Hoe H.S., Zarkowsky D., Lee S.H., Isaac J.T.,
RA   Pak D.T.;
RT   "Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic
RT   overexcitation.";
RL   Nat. Neurosci. 13:1199-1207(2010).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF LYS-108 AND THR-236.
RX   PubMed=21382555; DOI=10.1016/j.neuron.2011.02.004;
RA   Lee K.J., Lee Y., Rozeboom A., Lee J.Y., Udagawa N., Hoe H.S., Pak D.T.;
RT   "Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic
RT   structural plasticity, and memory.";
RL   Neuron 69:957-973(2011).
CC   -!- FUNCTION: Tumor suppressor serine/threonine-protein kinase involved in
CC       synaptic plasticity, centriole duplication and G1/S phase transition.
CC       Polo-like kinases act by binding and phosphorylating proteins that are
CC       already phosphorylated on a specific motif recognized by the POLO box
CC       domains. Phosphorylates CENPJ, NPM1, RAPGEF2, RASGRF1, SNCA, SIPA1L1
CC       and SYNGAP1. Plays a key role in synaptic plasticity and memory by
CC       regulating the Ras and Rap protein signaling: required for
CC       overactivity-dependent spine remodeling by phosphorylating the Ras
CC       activator RASGRF1 and the Rap inhibitor SIPA1L1 leading to their
CC       degradation by the proteasome. Conversely, phosphorylates the Rap
CC       activator RAPGEF2 and the Ras inhibitor SYNGAP1, promoting their
CC       activity. Also regulates synaptic plasticity independently of kinase
CC       activity, via its interaction with NSF that disrupts the interaction
CC       between NSF and the GRIA2 subunit of AMPARs, leading to a rapid rundown
CC       of AMPAR-mediated current that occludes long term depression. Required
CC       for procentriole formation and centriole duplication by phosphorylating
CC       CENPJ and NPM1, respectively. Its induction by p53/TP53 suggests that
CC       it may participate in the mitotic checkpoint following stress.
CC       {ECO:0000269|PubMed:10523297, ECO:0000269|PubMed:18498738,
CC       ECO:0000269|PubMed:18723513, ECO:0000269|PubMed:20802490,
CC       ECO:0000269|PubMed:21382555}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.21;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.21;
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation of Thr-236. Once
CC       activated, activity is stimulated by binding target proteins (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CIB1 (By similarity). Interacts with NSF;
CC       causing NSF dissociation from GRIA2. {ECO:0000250,
CC       ECO:0000269|PubMed:10523297, ECO:0000269|PubMed:20802490}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome, centriole {ECO:0000250}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:10523297}. Note=Localizes to centrosomes during
CC       early G1 phase where it only associates to the mother centriole and
CC       then distributes equally to both mother and daughter centrioles at the
CC       onset of S phase. {ECO:0000250}.
CC   -!- DOMAIN: The POLO box domains act as phosphopeptide-binding module that
CC       recognizes and binds serine-[phosphothreonine/phosphoserine]-
CC       (proline/X) motifs. PLK2 recognizes and binds docking proteins that are
CC       already phosphorylated on these motifs, and then phosphorylates them
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: Catalytic activity is enhanced by phosphorylation of Thr-236.
CC       {ECO:0000269|PubMed:20802490}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. CDC5/Polo subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF136583; AAF08366.1; -; mRNA.
DR   EMBL; BC070878; AAH70878.1; -; mRNA.
DR   RefSeq; NP_114009.1; NM_031821.1.
DR   AlphaFoldDB; Q9R012; -.
DR   SMR; Q9R012; -.
DR   BioGRID; 249816; 5.
DR   IntAct; Q9R012; 1.
DR   MINT; Q9R012; -.
DR   STRING; 10116.ENSRNOP00000016768; -.
DR   iPTMnet; Q9R012; -.
DR   PhosphoSitePlus; Q9R012; -.
DR   PaxDb; 10116-ENSRNOP00000016768; -.
DR   Ensembl; ENSRNOT00000016768.5; ENSRNOP00000016768.3; ENSRNOG00000011951.5.
DR   Ensembl; ENSRNOT00055019942; ENSRNOP00055016070; ENSRNOG00055011728.
DR   Ensembl; ENSRNOT00060006581; ENSRNOP00060004930; ENSRNOG00060003936.
DR   Ensembl; ENSRNOT00065033443; ENSRNOP00065026746; ENSRNOG00065019840.
DR   GeneID; 83722; -.
DR   KEGG; rno:83722; -.
DR   AGR; RGD:620760; -.
DR   CTD; 10769; -.
DR   RGD; 620760; Plk2.
DR   eggNOG; KOG0575; Eukaryota.
DR   GeneTree; ENSGT00940000158739; -.
DR   HOGENOM; CLU_000288_46_1_1; -.
DR   InParanoid; Q9R012; -.
DR   OrthoDB; 5471704at2759; -.
DR   PhylomeDB; Q9R012; -.
DR   TreeFam; TF101089; -.
DR   BRENDA; 2.7.11.21; 5301.
DR   Reactome; R-RNO-6804115; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain.
DR   PRO; PR:Q9R012; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000011951; Expressed in frontal cortex and 20 other cell types or tissues.
DR   GO; GO:0005814; C:centriole; ISS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0000776; C:kinetochore; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0000922; C:spindle pole; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043008; F:ATP-dependent protein binding; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; IPI:RGD.
DR   GO; GO:0032050; F:clathrin heavy chain binding; IPI:RGD.
DR   GO; GO:0051020; F:GTPase binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0060292; P:long-term synaptic depression; IDA:UniProtKB.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IDA:UniProtKB.
DR   GO; GO:0007613; P:memory; ISS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; ISO:RGD.
DR   GO; GO:0007052; P:mitotic spindle organization; ISS:UniProtKB.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0071866; P:negative regulation of apoptotic process in bone marrow cell; ISO:RGD.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; ISO:RGD.
DR   GO; GO:0061000; P:negative regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IMP:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISO:RGD.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:RGD.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; IMP:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032486; P:Rap protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0046599; P:regulation of centriole replication; ISS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IDA:UniProtKB.
DR   GO; GO:0140252; P:regulation protein catabolic process at postsynapse; IDA:SynGO.
DR   CDD; cd13118; POLO_box_1; 1.
DR   CDD; cd13117; POLO_box_2; 1.
DR   CDD; cd14188; STKc_PLK2; 1.
DR   Gene3D; 3.30.1120.30; POLO box domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR042825; PLK2_STKc.
DR   InterPro; IPR033701; POLO_box_1.
DR   InterPro; IPR033695; POLO_box_2.
DR   InterPro; IPR000959; POLO_box_dom.
DR   InterPro; IPR036947; POLO_box_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24345; SERINE/THREONINE-PROTEIN KINASE PLK; 1.
DR   PANTHER; PTHR24345:SF44; SERINE_THREONINE-PROTEIN KINASE PLK2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00659; POLO_box; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF82615; Polo-box domain; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50078; POLO_BOX; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell projection; Cytoplasm; Cytoskeleton; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Tumor suppressor.
FT   CHAIN           1..682
FT                   /note="Serine/threonine-protein kinase PLK2"
FT                   /id="PRO_0000086563"
FT   DOMAIN          79..331
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          500..578
FT                   /note="POLO box 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00154"
FT   DOMAIN          598..682
FT                   /note="POLO box 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00154"
FT   REGION          25..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          402..430
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        402..417
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        202
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305"
FT   BINDING         85..93
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         108
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         236
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20802490"
FT   MUTAGEN         108
FT                   /note="K->M: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:20802490,
FT                   ECO:0000269|PubMed:21382555"
FT   MUTAGEN         202
FT                   /note="D->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:18723513"
FT   MUTAGEN         236
FT                   /note="T->E: Mimicks phosphorylation state, leading to
FT                   increased activity."
FT                   /evidence="ECO:0000269|PubMed:20802490,
FT                   ECO:0000269|PubMed:21382555"
FT   MUTAGEN         504
FT                   /note="W->A: Abolishes interaction with SIPA1L1."
FT                   /evidence="ECO:0000269|PubMed:18498738,
FT                   ECO:0000269|PubMed:20802490"
FT   MUTAGEN         504
FT                   /note="W->F: Does not affect interaction with NSF and
FT                   ability to dissociate NSF from GRIA2."
FT                   /evidence="ECO:0000269|PubMed:18498738,
FT                   ECO:0000269|PubMed:20802490"
SQ   SEQUENCE   682 AA;  77920 MW;  58C50DEBDE83D5F3 CRC64;
     MELLRTITYQ PAAGTKMCEQ ALGKACGGDS KKKRPQQPSE DGQSQAQVTP AAPHHHHHHS
     HSGPEISRII VDPTTGKRYC RGKVLGKGGF AKCYEMTDLT NNKVYAAKII PHSRVAKPHQ
     REKIDKEIEL HRILHHKHVV QFYHYFEDKE NIYILLEYCS RRSMAHILKA RKVLTEPEVR
     YYLRQIVSGL KYLHEQEILH RDLKLGNFFI NEAMELKVGD FGLAARLEPL EHRRRTICGT
     PNYLSPEVLN KQGHGCESDI WALGCVMYTM LLGRPPFETT NLKETYRCIR EARYTMPSSL
     LAPAKHLIAS MLSKNPEDRP SLDDIIRHDF FLQGFTPDRL SSSCCHTVPD FHLSSPAKNF
     FKKAAAALFG GKKDKARYND THNKVSKEDE DIYKLRHDLK KTSITQQPSK HRTDEELQPP
     PTTFAKSGTS AVENKQQIGD AIRMIVRGTL GSCSSSSECL EDSTMGSVAD TVARVLRGCL
     ENMPEADCIP KEQLSTSFQW VTKWVDYSNK YGFGYQLSDH TVGVLFNNGA HMSLLPDKKT
     VHYYAELGQC SVFPATDAPE QFISQVTVLK YFSHYMEENL MDGGDLPSVT DIRRPRLYLL
     QWLKSDKALM MLFNDGTFQV NFYHDHTKII ICNQNEEYLL TYINEDRIST TFRLTTLLMS
     GCSLELKHRM EYALNMLLQR CN
//
